Neoleukin Therapeutics (NGNE) Shares Outstanding (2014 - 2026)
Neoleukin Therapeutics (NGNE) shares outstanding from Mar 31, 2014 to Mar 31, 2026. The current Neoleukin Therapeutics (NGNE) shares outstanding is 15.62M. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Shares Outstanding
Neoleukin Therapeutics (NGNE) Shares Outstanding CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +7.83% |
| 3 Years TTM | +12.13% |
| 5 Years TTM | +7.85% |
| 10 Years TTM | +14.46% |
| All Time TTM | +24.59% |
Annual Shares Outstanding change of Neoleukin Therapeutics (NGNE)
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 | 15.62M | +0.81% |
| 2025 | 15.49M | +4.28% |
| 2024 | 14.85M | +15.84% |
| 2023 | 12.82M | +20.27% |
| 2022 | 10.66M | +0.45% |
| 2021 | 10.61M | +0.62% |
| 2020 | 10.55M | +11.05% |
| 2019 | 9.50M | +61.43% |
| 2018 | 5.88M | +0.28% |
| 2017 | 5.87M | +0.21% |
| 2016 | 5.86M | +36.09% |
| 2015 | 4.30M | +60.93% |
| 2014 | 2.67M | N/A |